http://www.inveslogic.com/tags/phase Blog Articles Tagged with 'phase' at http://www.inveslogic.com en http://www.inveslogic.com/sectors/directory/etf-investor/1147641?rsstype=tag&tag=phase Earlier this week BioSante Pharma (BPAX) reported 3Q08 results which included a net loss of $6.6M or ($0.24) per share and a loss of $16.3M or ($0.60) per share for the first nine months of the year. The primary focus at the company is the developmen... Fri, 14 Nov 2008 14:57:43 -0500 http://www.inveslogic.com/sectors/directory/etf-investor/1147641?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1147308?rsstype=tag&tag=phase Recent headlines that Susquehanna analysts have downgraded their rating on Human Genome Sciences (HGSI) from positive to neutral , whilst negative for sentiment, may have initially appeared relatively innocuous given the tough financial cl... Fri, 14 Nov 2008 04:13:33 -0500 http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1147308?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/etf-investor/1147341?rsstype=tag&tag=phase Recent headlines that Susquehanna analysts have downgraded their rating on Human Genome Sciences (HGSI) from positive to neutral , whilst negative for sentiment, may have initially appeared relatively innocuous given the tough financial cl... Fri, 14 Nov 2008 04:13:33 -0500 http://www.inveslogic.com/sectors/directory/etf-investor/1147341?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/a-canadian-econoview/1146501?rsstype=tag&tag=phase THE NEXT PHASE BEGINS IN MINNESOTA.... With the razor-thin margin in the Senate race in Minnesota, the first phase in the Republican strategy was to argue that a statewide recount was a waste of time. It was unpersuasive. So, the...... Wed, 12 Nov 2008 14:30:03 -0500 http://www.inveslogic.com/sectors/directory/a-canadian-econoview/1146501?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/etf-investor/1146485?rsstype=tag&tag=phase A welcome sign of independent intelligent life at the NYT business section comes this morning, with Edmund Andrews' piece on Frannie's latest loan-mod plan. Both the WSJ and the FT played the story just as Treasury and FHFA wanted them to; the WSJ ev... Wed, 12 Nov 2008 11:48:40 -0500 http://www.inveslogic.com/sectors/directory/etf-investor/1146485?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/etf-investor/1145984?rsstype=tag&tag=phase The Money: $3.375 billion: $1.25 billion cash upfront; $2.125 billion in drilling costs over 2009-2012. The Position: Chesapeake Energy (CHK) gives up 32.5% of their Marcellus position (or 600,000 acres of their 1.8 million acre position). T... Tue, 11 Nov 2008 13:08:46 -0500 http://www.inveslogic.com/sectors/directory/etf-investor/1145984?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/etf-investor/1146001?rsstype=tag&tag=phase ArQule and Daiichi Sankyo announced that they have entered into two agreements that form the basis of a strategic relationship for the development and discovery of novel oncology therapeutics. One agreement covers the license of ARQ 197 and the othe... Tue, 11 Nov 2008 11:13:49 -0500 http://www.inveslogic.com/sectors/directory/etf-investor/1146001?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1146083?rsstype=tag&tag=phase ArQule and Daiichi Sankyo announced that they have entered into two agreements that form the basis of a strategic relationship for the development and discovery of novel oncology therapeutics. One agreement covers the license of ARQ 197 and the othe... Tue, 11 Nov 2008 11:13:49 -0500 http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1146083?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/in-the-pipeline/1146244?rsstype=tag&tag=phase The painful saga of Acomplia (rimonabant) has finally come to an end. Sanofi-Aventis has announced that they're completely giving up on the drug. There was really no other option - the compound was never approved in the US, and was never going to be,... Thu, 06 Nov 2008 08:16:16 -0500 http://www.inveslogic.com/sectors/directory/in-the-pipeline/1146244?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/etf-investor/1142925?rsstype=tag&tag=phase Stock markets enjoyed a well-deserved relief rally last week, repairing some of the damage sustained in the free-fall that began in late September. In the dreadful five-week period from September 22 to October 24, the MSCI All-Country World Index (AC... Tue, 04 Nov 2008 03:29:26 -0500 http://www.inveslogic.com/sectors/directory/etf-investor/1142925?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/etf-investor/1141734?rsstype=tag&tag=phase Theratechnologies and EMD Serono, US arm of Merck KGaA (MKGAY.PK), announced they have entered into a collaboration and licensing agreement for the exclusive commercialization rights to tesamorelin in the United States for the treatment of excess ... Fri, 31 Oct 2008 06:44:29 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1141734?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1141616?rsstype=tag&tag=phase Rigel Pharmceuticals' (RIGL) shares have lost almost half their value this week since the release of fresh data from a phase II study of its lead product, R788 in rheumatoid arthritis, which considering the new information was neither overwhelmingly ... Fri, 31 Oct 2008 03:14:04 -0400 http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1141616?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/etf-investor/1141044?rsstype=tag&tag=phase China Sky One Medical (CSKI) has bought a proprietary breast lesion drug from Harbin Medical University for 10 million RMB ($1.5 million). The drug, which China Sky One and Harbin developed jointly, has completed its Phase I trial. In the more than 1... Thu, 30 Oct 2008 06:22:44 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1141044?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/etf-investor/1139915?rsstype=tag&tag=phase Phase Forward Incorporated (PFWD)Q3 2008 Earnings Call ... Mon, 27 Oct 2008 22:29:13 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1139915?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/health-business-blog/1139949?rsstype=tag&tag=phase This is a transcript of my podcast interview with Dr. Ralph Kalies, CEO of BidRx.David Williams: This is David Williams, co-founder of MedPharma Partners and author of the Health Business Blog. I am speaking today with Dr. Ralph Kalies, he is CEO o... Mon, 27 Oct 2008 22:09:11 -0400 http://www.inveslogic.com/sectors/directory/health-business-blog/1139949?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/etf-investor/1136001?rsstype=tag&tag=phase On the surface, Google (GOOG) appeared to soundly beat analyst expectations of $4.76, by reportingdiluted earnings per share of $4.92, on a top line of $ 4.04 billion (see conference call transcript). GOOG s revenues were $20 million short of analy... Fri, 17 Oct 2008 09:16:15 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1136001?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/in-the-pipeline/1136100?rsstype=tag&tag=phase Here's a good article over at the In Vivo Blog on this year's crop of expensive Phase III failures. They've mostly been biotech drugs (vaccines and the like), but it's a problem everywhere. As In Vivo's Chris Morrison puts it:Look, drugs fail. That h... Fri, 17 Oct 2008 08:49:31 -0400 http://www.inveslogic.com/sectors/directory/in-the-pipeline/1136100?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1135067?rsstype=tag&tag=phase It finally happened. Yesterday, Genentech (DNA) announced that they made a go decision to advance T-DM1 into a phase III trial. Although no official announcement is out as of yet, Genentech's President of Product Development, Sue Hellmann, left... Wed, 15 Oct 2008 10:53:29 -0400 http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1135067?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/a-canadian-econoview/1134375?rsstype=tag&tag=phase THE STAKES.... Looking back over the last couple of months, as the general election phase of the campaign began in earnest, one of my very favorite quotes came from McCain campaign manager Rick Davis: This election is not about issues. ...... Tue, 14 Oct 2008 04:30:06 -0400 http://www.inveslogic.com/sectors/directory/a-canadian-econoview/1134375?rsstype=tag&tag=phase http://www.inveslogic.com/sectors/directory/india-stock-blog/1134976?rsstype=tag&tag=phase What is the outlook for India s outsourcing industry amidst the market turmoil? The Indian IT major, Infosys Technologies (INFY) had expressed its concerns about the recession when the company announced its Q407 results earlier this year. Its Q2 re... Mon, 13 Oct 2008 12:56:00 -0400 http://www.inveslogic.com/sectors/directory/india-stock-blog/1134976?rsstype=tag&tag=phase